Kensey Nash Corporation Earnings Conference Call (Q1 2010)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 22 Calls Today's Calls

Call Details Kensey Nash Corporation Earnings Conference Call (Q1 2010) Thu, Oct 22, 2009, 9:00 am Eastern Listen to the archived event audio About Kensey Nash Corporation (NasdaqGS:KNSY) Kensey Nash Corporation, a medical device company, develops products and technologies in the fields of resorbable biomaterials and endovascular devices used in various medical procedures. The company develops, manufactures, and processes resorbable biomaterials products incorporating its proprietary collagen and synthetic polymer technology. It offers Angio-Seal components; orthopaedic products for various applications of biomaterials, which include soft tissue and bone fixation, and bone void fillers and scaffolds; and biomaterials-based products, including resorbable breast biopsy markers, dental barrier membranes, and wound care products designed for other market applications. The company sells its products to multiple medical markets, primarily in the cardiology, orthopaedic, sports medicine, spine, endovascular, and general surgery. The company distributes its endovascular products through direct sales force primarily in the United States and Germany, as well as through distributors in Europe, Russia, and India. It has strategic agreement with Synthes, Inc., under which the company would develop and manufacture porcine dermis-based Medeor matrix ECM products. The company was incorporated in 1984 and is headquartered in Exton, Pennsylvania. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings